[1] DuanW, Chan JH, Wong CH, et al. Anti-inflammatory effects ofmitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model [J]. J Immunol, 2004,172(11):7053-7059. [2] 白晶,刘先胜,徐永健,等. ERK在慢性哮喘大鼠气道平滑肌细胞增殖中的作用[J]. 中国病理生理杂志, 2008,24(3):417-422. [3] Bureau F, Bonizzi G, Kirschvink N, et al. Correlation between nuclear factor-kappaB activity in bronchial brushing samples and lung dysfunction in an animal model of asthma[J]. Am J Respir Crit Care Med, 2000,161(4 Pt 1):1314-1321. [4] Langelot M, Cellerin L, Germaud P. Anti-inflammatory effects of macrolides: applications in lung disease[J]. Rev Pneumol Clin, 2006,62(4):215-222. [5] 王传夏,李昌崇,罗运春,等. 支气管哮喘大鼠气道重塑中肺泡巨噬细胞的作用[J]. 中华结核和呼吸杂志, 2006,29(11):740-743. [6] Barnes PJ. Nuclear factor-kappa B[J]. Int J Biochem Cell Biol, 1997,29(6):867-870. [7] Zhang JB,Wu CY,Li ZQ, et al. The effects of erythromycin on the expression of P38 and Th2 Cytokines to rats with asthma[J]. Chin J Clin Pharmacol Ther, 2009,14(10):1151-1155. [8] 张近波,吴成云,李智强,等.红霉素对哮喘大鼠核因子NF-κB及Th2类细胞因子的影响[J].中国临床药理学与治疗学, 2009,14(3):292-295. [9] Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action[J]. Pharmacol Ther, 2008,117(3):393-405. [10] Ichiyama T, Nishikawa M, Yoshitomi T, et al. Clarithromycin inhibits NF-kappaB activation in human peripheral blood mononuclear cells and pulmonary epithelial cells[J]. Antimicrob Agents Chemother, 2001,45(1):44. |